Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 10, Issue 3, Pages 536
Publisher
MDPI AG
Online
2021-02-02
DOI
10.3390/jcm10030536
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Shared decision making, thrombotic thrombocytopenic purpura, and caplacizumab
- (2020) Senthil Sukumar et al. AMERICAN JOURNAL OF HEMATOLOGY
- Interrelationship between ADAMTS13 activity, von Willebrand factor, and complement activation in remission from immune‐mediated trhrombotic thrombocytopenic purpura
- (2020) Haiwa Wu et al. BRITISH JOURNAL OF HAEMATOLOGY
- The development and characterization of a long acting anti‐thrombotic von Willebrand factor (VWF) aptamer
- (2020) Shuhao Zhu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR
- (2020) Kazuya Sakai et al. BLOOD
- Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
- (2020) Elien Roose et al. BLOOD
- A multi‐center evaluation of TECHNOSCREEN ® ADAMTS‐13 activity assay as a screening tool for detecting deficiency of ADAMTS‐13
- (2020) Gary W. Moore et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Caplacizumab for treatment of thrombotic thrombocytopenic purpura in a patient with anaphylaxis to fresh‐frozen plasma
- (2020) Mehraboon S. Irani et al. TRANSFUSION
- ISTH Guidelines for Treatment of Thrombotic Thrombocytopenic Purpura
- (2020) X. Long Zheng et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Good Practice Statements (GPS) for the Clinical Care of Patients with Thrombotic Thrombocytopenic Purpura
- (2020) X. Long Zheng et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Treatment of acquired thrombotic thrombocytopenic purpura without plasma exchange in selected patients under caplacizumab
- (2020) Linus A. Völker et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Comparison of low fixed dose versus standard-dose rituximab to treat thrombotic thrombocytopenic purpura in the acute phase and preemptively during remission
- (2020) Manasa S. Reddy et al. TRANSFUSION AND APHERESIS SCIENCE
- The HLA Variant rs6903608 Is Associated with Disease Onset and Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Caucasians
- (2020) Ilaria Mancini et al. Journal of Clinical Medicine
- Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
- (2019) Marie Scully et al. NEW ENGLAND JOURNAL OF MEDICINE
- The International Hereditary Thrombotic Thrombocytopenic Purpura Registry: Key findings at enrolment until 2017
- (2019) Hendrika A. van Dorland et al. HAEMATOLOGICA
- Comparison of the Long-Term Remission of Rituximab and Conventional Treatment for Acquired Thrombotic Thrombocytopenic Purpura: A Systematic Review and Meta-Analysis
- (2019) Weerapat Owattanapanich et al. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS
- Characterization and treatment of congenital thrombotic thrombocytopenic purpura
- (2019) Ferras Alwan et al. BLOOD
- Adjuvant low-dose rituximab and plasma exchange for acquired TTP
- (2019) Jeffrey I. Zwicker et al. BLOOD
- Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura
- (2019) Deepak P. Chander et al. NEW ENGLAND JOURNAL OF MEDICINE
- Synergistic effects of ADAMTS13 deficiency and complement activation in pathogenesis of thrombotic microangiopathy
- (2019) Liang Zheng et al. BLOOD
- Reduced ADAMTS13 activity during TTP remission is associated with stroke in TTP survivors
- (2019) Harshvardhan Upreti et al. BLOOD
- Severely Deficient ADAMTS13 Activity Predicts Relapse of Immune-Mediated Thrombotic Thrombocytopenic Purpura in Pregnancy
- (2019) Camila Masias et al. BLOOD
- Hereditary Thrombotic Thrombocytopenic Purpura
- (2019) Johanna A. Kremer Hovinga et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incidence of acquired thrombotic thrombocytopenic purpura in Germany: a hospital level study
- (2019) Wolfgang Miesbach et al. Orphanet Journal of Rare Diseases
- Evaluation of a New, Rapid, Fully Automated Assay for the Measurement of ADAMTS13 Activity
- (2019) Carla Valsecchi et al. THROMBOSIS AND HAEMOSTASIS
- Crystal structure and substrate-induced activation of ADAMTS13
- (2019) Anastasis Petri et al. Nature Communications
- Novel aptamer to von Willebrand factor A1 domain (TAGX-0004) shows total inhibition of thrombus formation superior to ARC1779 and comparable to caplacizumab
- (2019) Kazuya Sakai et al. HAEMATOLOGICA
- Efficacy and safety of open‐label caplacizumab in patients with exacerbations of acquired thrombotic thrombocytopenic purpura in the HERCULES study
- (2019) Paul Knoebl et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis
- (2018) Camila Masias et al. BLOOD
- Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
- (2018) Johana Hrdinová et al. HAEMATOLOGICA
- Pathophysiology of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome
- (2018) J. A. Kremer Hovinga et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- An open conformation of ADAMTS-13 is a hallmark of acute acquired thrombotic thrombocytopenic purpura
- (2018) E. Roose et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Evaluation of the Fully Automated HemosIL Acustar ADAMTS13 Activity Assay
- (2018) Julien Favresse et al. THROMBOSIS AND HAEMOSTASIS
- Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
- (2018) Johana Hrdinová et al. HAEMATOLOGICA
- Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura
- (2018) Matthieu Jestin et al. BLOOD
- Relapse Rate in Survivors of Acute Autoimmune Thrombotic Thrombocytopenic Purpura Treated with or without Rituximab
- (2018) Stephanie Herold et al. THROMBOSIS AND HAEMOSTASIS
- ADAMTS13 kinetics after therapeutic plasma exchange and plasma infusion in patients with Upshaw-Schulman syndrome
- (2018) Petra Kovarova et al. JOURNAL OF CLINICAL APHERESIS
- Pharmacokinetics of plasma infusion in congenital thrombotic thrombocytopenic purpura
- (2018) A. Taylor et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ADAMTS13 Gene Mutations Influence ADAMTS13 Conformation and Disease Age-Onset in the French Cohort of Upshaw–Schulman Syndrome
- (2018) Bérangère Joly et al. THROMBOSIS AND HAEMOSTASIS
- ADAMTS13-specific circulating immune complexes as potential predictors of relapse in patients with acquired thrombotic thrombocytopenic purpura
- (2017) Ilaria Mancini et al. European Journal of Internal Medicine
- Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies
- (2017) M. Scully et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Post-traumatic stress disorder and depression in survivors of thrombotic thrombocytopenic purpura
- (2017) Shruti Chaturvedi et al. THROMBOSIS RESEARCH
- Depression and cognitive deficits as long-term consequences of thrombotic thrombocytopenic purpura
- (2017) Tanja Falter et al. TRANSFUSION
- Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial
- (2017) Lynne Uhl et al. TRANSFUSION
- Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study
- (2017) Pavan K Bendapudi et al. Lancet Haematology
- Von Willebrand Factor, ADAMTS13, and the Risk of MortalityHighlights
- (2016) Michelle A.H. Sonneveld et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- N-acetylcysteine in preclinical mouse and baboon models of thrombotic thrombocytopenic purpura
- (2016) Claudia Tersteeg et al. BLOOD
- Rituximab reduces risk for relapse in patients with thrombotic thrombocytopenic purpura
- (2016) E. E. Page et al. BLOOD
- Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura
- (2016) E. E. Page et al. BLOOD
- Bortezomib in the treatment of refractory thrombotic thrombocytopenic purpura
- (2016) Christopher J. Patriquin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP/thrombotic microangiopathy registry
- (2016) P. Blombery et al. INTERNAL MEDICINE JOURNAL
- Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam Study
- (2016) M. A. H. Sonneveld et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observation to evidence
- (2016) A. S. von Krogh et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
- (2016) Flora Peyvandi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy
- (2016) Bérangère S Joly et al. Lancet Haematology
- Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy
- (2016) Eric Mariotte et al. Lancet Haematology
- Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
- (2016) Suella Martino et al. PLoS One
- A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel
- (2015) Nadav Rinott et al. ACTA HAEMATOLOGICA
- Increased morbidity during long-term follow-up of survivors of thrombotic thrombocytopenic purpura
- (2015) Shruti Chaturvedi et al. AMERICAN JOURNAL OF HEMATOLOGY
- Low ADAMTS13 activity is associated with an increased risk of ischemic stroke
- (2015) M. A. H. Sonneveld et al. BLOOD
- The utility of ADAMTS13 in differentiating TTP from other acute thrombotic microangiopathies: results from the UK TTP Registry
- (2015) Sevda Hassan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ultralarge Von Willebrand Factor–Induced Platelet Clumping and Activation of the Alternative Complement Pathway in Thrombotic Thrombocytopenic Purpura and the Hemolytic-Uremic Syndromes
- (2015) Nancy Turner et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Acute renal failure is prevalent in patients with thrombotic thrombocytopenic purpura associated with low plasma ADAMTS13 activity
- (2015) L. Zafrani et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13
- (2015) L. Deforche et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Establishment of the WHO 1st International Standard ADAMTS13, plasma (12/252): communication from the SSC of the ISTH
- (2015) A. R. Hubbard et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of N-acetylcysteine in the treatment of thrombotic thrombocytopenic purpura
- (2015) Amihai Rottenstreich et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
- (2015) Mélanie Roriz et al. MEDICINE
- Type of plasma preparation used for plasma exchange and clinical outcome of adult patients with acquired idiopathic thrombotic thrombocytopenic purpura: a French retrospective multicenter cohort study
- (2015) Marie Toussaint-Hacquard et al. TRANSFUSION
- Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura
- (2015) Mari R. Thomas et al. EBioMedicine
- Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura
- (2014) M. Hie et al. BLOOD
- von Willebrand factor is a cofactor in complement regulation
- (2014) S. Feng et al. BLOOD
- Thrombotic thrombocytopenic purpura and pregnancy: presentation, management, and subsequent pregnancy outcomes
- (2014) M. Scully et al. BLOOD
- Acquired TTP: ADAMTS13 meets the immune system
- (2014) Fabian C. Verbij et al. BLOOD REVIEWS
- Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura
- (2014) R. Grillberger et al. HAEMATOLOGICA
- Cardiac troponin-I on diagnosis predicts early death and refractoriness in acquired thrombotic thrombocytopenic purpura. Experience of the French Thrombotic Microangiopathies Reference Center
- (2014) Y. Benhamou et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Syndromes of Thrombotic Microangiopathy
- (2014) James N. George et al. NEW ENGLAND JOURNAL OF MEDICINE
- Allosteric activation of ADAMTS13 by von Willebrand factor
- (2014) Joshua Muia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conformational activation of ADAMTS13
- (2014) Kieron South et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evaluation of a chromogenic commercial assay using VWF-73 peptide for ADAMTS13 activity measurement
- (2014) Bérangère Joly et al. THROMBOSIS RESEARCH
- Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura
- (2013) C. C. Deford et al. BLOOD
- Complement and cytokine response in acute Thrombotic Thrombocytopenic Purpura
- (2013) John-Paul Westwood et al. BRITISH JOURNAL OF HAEMATOLOGY
- Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura
- (2013) S. Ferrari et al. HAEMATOLOGICA
- Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research
- (2013) Ravi Sarode et al. JOURNAL OF CLINICAL APHERESIS
- Complement Activation and Mortality During an Acute Episode of Thrombotic Thrombocytopenic Purpura
- (2013) Trudy C Wu et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Measurement and prevalence of circulating ADAMTS13-specific immune complexes in autoimmune thrombotic thrombocytopenic purpura
- (2013) L. A. Lotta et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ADAMTS13 Antibody Depletion by Bortezomib in Thrombotic Thrombocytopenic Purpura
- (2013) Jake Shortt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: Comparison of incidence, demographic and clinical features
- (2013) Jessica A. Reese et al. PEDIATRIC BLOOD & CANCER
- Evaluation of a commercial assay for ADAMTS13 activity measurement
- (2013) Sandrine Thouzeau et al. THROMBOSIS AND HAEMOSTASIS
- Treatment of refractory thrombotic thrombocytopenic purpura withN-acetylcysteine: a case report
- (2013) Gloria W. Li et al. TRANSFUSION
- Performance of a clinical prediction score for thrombotic thrombocytopenic purpura in an independent cohort
- (2013) M. J. Bentley et al. VOX SANGUINIS
- A second hit for TMA
- (2012) T. Miyata et al. BLOOD
- Circulating DNA and myeloperoxidase indicate disease activity in patients with thrombotic microangiopathies
- (2012) T. A. Fuchs et al. BLOOD
- Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura
- (2012) M. Moatti-Cohen et al. BLOOD
- Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura
- (2012) L. A. Lotta et al. BLOOD
- Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies
- (2012) Marie Scully et al. BRITISH JOURNAL OF HAEMATOLOGY
- Ten patient stories illustrating the extraordinarily diverse clinical features of patients with thrombotic thrombocytopenic purpura and severe ADAMTS13 deficiency
- (2012) James N. George et al. JOURNAL OF CLINICAL APHERESIS
- Complement activation in thrombotic thrombocytopenic purpura
- (2012) M. RÉTI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura
- (2012) G. BETTONI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Ticlopidine-, Clopidogrel-, and Prasugrel-Associated Thrombotic Thrombocytopenic Purpura: A 20-Year Review from the Southern Network on Adverse Reactions (SONAR)
- (2012) Sony Jacob et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Generation and Breakdown of Soluble Ultralarge von Willebrand Factor Multimers
- (2012) Nancy Turner et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Splenectomy and/or cyclophosphamide as salvage therapies in thrombotic thrombocytopenic purpura: the French TMA Reference Center experience
- (2012) François Beloncle et al. TRANSFUSION
- Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura
- (2011) Spero R. Cataland et al. AMERICAN JOURNAL OF HEMATOLOGY
- The role of human leukocyte antigens as predisposing and/or protective factors in patients with idiopathic thrombotic thrombocytopenic purpura
- (2011) Marie-Luise John et al. ANNALS OF HEMATOLOGY
- A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura
- (2011) M. Scully et al. BLOOD
- Human immunodeficiency virus associated thrombotic thrombocytopenic purpura - favourable outcome with plasma exchange and prompt initiation of highly active antiretroviral therapy
- (2011) Daniel Hart et al. BRITISH JOURNAL OF HAEMATOLOGY
- Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center
- (2011) Antoine Froissart et al. CRITICAL CARE MEDICINE
- Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain
- (2011) W. Pos et al. HAEMATOLOGICA
- Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience
- (2011) Moon Ju Jang et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice
- (2011) Junmei Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- Recombinant ADAMTS13 normalizes von Willebrand factor-cleaving activity in plasma of acquired TTP patients by overriding inhibitory antibodies
- (2011) B. PLAIMAUER et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan
- (2011) Y. FUJIMURA et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura
- (2011) Yusuke Yamaguchi et al. THROMBOSIS RESEARCH
- Evidence of persistent neurologic injury following thrombotic thrombocytopenic purpura
- (2010) Spero R. Cataland et al. AMERICAN JOURNAL OF HEMATOLOGY
- A Case of Severe Thrombotic Thrombocytopenic Purpura With Concomitant Legionella Pneumonia: Review of Pathogenesis and Treatment
- (2010) Tony Talebi et al. AMERICAN JOURNAL OF THERAPEUTICS
- Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura
- (2010) X. L. Zheng et al. HAEMATOLOGICA
- Influenza A Infection Triggers Thrombotic Thrombocytopenic Purpura by Producing the Anti-ADAMTS13 IgG Inhibitor
- (2010) Nobuharu Kosugi et al. INTERNAL MEDICINE
- Registry of 919 Patients with Thrombotic Microangiopathies across Japan: Database of Nara Medical University during 1998-2008
- (2010) Yoshihiro Fujimura et al. INTERNAL MEDICINE
- HLA-DRB1*11: a strong risk factor for acquired severe ADAMTS13 deficiency-related idiopathic thrombotic thrombocytopenic purpura in Caucasians
- (2010) P. COPPO et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Predictive Features of Severe Acquired ADAMTS13 Deficiency in Idiopathic Thrombotic Microangiopathies: The French TMA Reference Center Experience
- (2010) Paul Coppo et al. PLoS One
- Cyclosporine therapy in refractory/relapsed patients with thrombotic thrombocytopenic purpura
- (2009) Annamaria Nosari et al. AMERICAN JOURNAL OF HEMATOLOGY
- High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study
- (2009) Carlo L. Balduini et al. ANNALS OF HEMATOLOGY
- Lower levels of ADAMTS13 are associated with cardiovascular disease in young patients
- (2009) T.N. Bongers et al. ATHEROSCLEROSIS
- A novel binding site for ADAMTS13 constitutively exposed on the surface of globular VWF
- (2009) S. Zanardelli et al. BLOOD
- Survival and relapse in patients with thrombotic thrombocytopenic purpura
- (2009) J. A. K. Hovinga et al. BLOOD
- ADAMTS13mutations and polymorphisms in congenital thrombotic thrombocytopenic purpura
- (2009) Luca A. Lotta et al. HUMAN MUTATION
- Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura
- (2009) R. S. CAMILLERI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura
- (2009) S. FERRARI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Human leukocyte antigen association in idiopathic thrombotic thrombocytopenic purpura: evidence for an immunogenetic link
- (2009) M. SCULLY et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Mechanoenzymatic Cleavage of the Ultralarge Vascular Protein von Willebrand Factor
- (2009) X. Zhang et al. SCIENCE
- Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases
- (2009) Tomomi Matsuyama et al. THROMBOSIS AND HAEMOSTASIS
- Effect of prophylactic cyclosporine therapy on ADAMTS13 biomarkers in patients with idiopathic thrombotic thrombocytopenic purpura
- (2008) Spero R. Cataland et al. AMERICAN JOURNAL OF HEMATOLOGY
- Relationship between ADAMTS13 activity in clinical remission and the risk of TTP relapse
- (2008) Ming Jin et al. BRITISH JOURNAL OF HAEMATOLOGY
- Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features
- (2008) Marie Scully et al. BRITISH JOURNAL OF HAEMATOLOGY
- ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
- (2008) F. Peyvandi et al. HAEMATOLOGICA
- Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13)
- (2008) A. TRIPODI et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Human Immunodeficiency Virus-Associated Thrombotic Microangiopathies: Clinical Characteristics and Outcome According to ADAMTS13 Activity
- (2008) S. Malak et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now